Salud financiera de hoja de balance de Amgen
Salud financiera controles de criterios 1/6
Amgen tiene un patrimonio de accionistas total de $5.0B y una deuda total de $64.0B, lo que sitúa su ratio deuda-patrimonio en 1274.8%. Sus activos y pasivos totales son $93.0B y $88.0B respectivamente. El BAIT de Amgen es de $7.1B, por lo que su ratio de cobertura de intereses es de 2.2. Tiene efectivo e inversiones a corto plazo que ascienden a $9.7B.
Información clave
1,274.8%
Ratio deuda-patrimonio
US$64.02b
Deuda
| Ratio de cobertura de intereses | 2.2x |
| Efectivo | US$9.71b |
| Patrimonio | US$5.02b |
| Total pasivo | US$87.96b |
| Activos totales | US$92.98b |
Actualizaciones recientes sobre salud financiera
Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Apr 01
Is Amgen (NASDAQ:AMGN) A Risky Investment?
Dec 28Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Sep 22Recent updates
The Price Is Right For Amgen Inc. (NASDAQ:AMGN)
Jul 11Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum
Jul 05Amgen: You Haven't Seen Anything Yet
Jun 17Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss Wild Card
Jun 04Amgen Stock: Poised To Break Out (Technical Analysis)
May 21Is Amgen Inc. (NASDAQ:AMGN) Trading At A 41% Discount?
May 04Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet
May 01Amgen: The Giant With An Impressive Pipeline
Apr 15Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Apr 01Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
Mar 31Amgen Will Benefit From Increased Medical Spending
Mar 12Amgen: A Good Dividend Growth Stock For The Watch List
Mar 04Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit
Feb 21Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now
Feb 16Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable
Feb 08Amgen: Accelerating The Business And Dividend Growth
Jan 29Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?
Jan 29Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks
Jan 22Is Amgen (NASDAQ:AMGN) A Risky Investment?
Dec 28Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors
Dec 13Are Investors Undervaluing Amgen Inc. (NASDAQ:AMGN) By 46%?
Oct 23Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Sep 22Do Amgen's (NASDAQ:AMGN) Earnings Warrant Your Attention?
Sep 04Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13
Aug 05Amgen Inc. (NASDAQ:AMGN) Shares Could Be 45% Below Their Intrinsic Value Estimate
May 30Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year
May 09Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($28.0B) de AMGN superan a sus pasivos a corto plazo ($19.7B).
Pasivo a largo plazo: Los activos a corto plazo ($28.0B) de AMGN no cubren sus pasivos a largo plazo ($68.2B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de AMGN (861.2%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de AMGN ha crecido de 304.9% a 1274.8% en los últimos 5 años.
Cobertura de la deuda: La deuda de AMGN no está bien cubierta por el flujo de caja operativo (13.1%).
Cobertura de intereses: Los pagos de intereses de la deuda de AMGN no están bien cubiertos por el BAIT (2.2x cobertura).